Joint Corp JYNT
Institutional shares held
10.9 Million
0
calls
261K
puts
Total value of holdings
$88.8M
$0
calls
$2.13M
puts
Market Cap
$118M
14,495,000
Shares Out.
Institutional ownership
75.18%
# of Institutions
87
We take great care to ensure that the data presented and summarized in this overview for JOINT Corp is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding JYNT
View all-
Bandera Partners LLC New York, NY3.94MShares$32.1 Million16.87% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.04MShares$8.51 Million0.0% of portfolio
-
Skylands Capital, LLC832KShares$6.78 Million1.29% of portfolio
-
Black Rock Inc. New York, NY809KShares$6.59 Million0.0% of portfolio
-
Jcp Investment Management, LLC594KShares$4.84 Million4.14% of portfolio
-
Geode Capital Management, LLC Boston, MA341KShares$2.78 Million0.0% of portfolio
-
State Street Corp Boston, MA290KShares$2.36 Million0.0% of portfolio
-
Alta Fox Capital Management, LLC Fort Worth, TX288KShares$2.35 Million0.84% of portfolio
-
First Foundation Advisors Irvine, CA274KShares$2.23 Million0.1% of portfolio
-
Goldman Sachs Group Inc New York, NY256KShares$2.08 Million0.0% of portfolio
Latest Institutional Activity in JYNT
Top Purchases
Top Sells
About JYNT
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Insider Transactions at JYNT
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 05
2025
|
Charles E Jobson |
BUY
Open market or private purchase
|
Direct |
10,000
+0.62%
|
$80,000
$8.41 P/Share
|
|
Dec 01
2025
|
Charles E Jobson |
BUY
Open market or private purchase
|
Direct |
13,000
+0.8%
|
$104,000
$8.41 P/Share
|
|
Nov 25
2025
|
Charles E Jobson |
BUY
Open market or private purchase
|
Direct |
2,081
+0.13%
|
$16,648
$8.43 P/Share
|
|
Nov 24
2025
|
Charles E Jobson |
BUY
Open market or private purchase
|
Direct |
4,680
+0.29%
|
$37,440
$8.36 P/Share
|
|
Nov 21
2025
|
Charles E Jobson |
BUY
Open market or private purchase
|
Direct |
10,000
+0.62%
|
$80,000
$8.5 P/Share
|
|
Aug 20
2025
|
Christopher M Grandpre |
BUY
Open market or private purchase
|
Direct |
10,000
+20.25%
|
$100,000
$10.41 P/Share
|
|
Aug 18
2025
|
Christopher M Grandpre |
BUY
Open market or private purchase
|
Direct |
10,000
+25.39%
|
$100,000
$10.7 P/Share
|
|
Aug 15
2025
|
Christopher M Grandpre |
BUY
Open market or private purchase
|
Direct |
14,388
+42.6%
|
$143,880
$10.88 P/Share
|
|
Jun 10
2025
|
Scott Justin Bowman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,984
+50.0%
|
-
|
|
Jun 03
2025
|
Sandra R Karrmann |
BUY
Grant, award, or other acquisition
|
Direct |
4,849
+50.0%
|
-
|
|
May 21
2025
|
Christopher M Grandpre |
BUY
Grant, award, or other acquisition
|
Direct |
4,995
+50.0%
|
-
|
|
May 21
2025
|
Abe Hong |
BUY
Grant, award, or other acquisition
|
Direct |
4,995
+16.04%
|
-
|
|
May 21
2025
|
Matthew E Rubel |
BUY
Grant, award, or other acquisition
|
Direct |
4,995
+22.24%
|
-
|
|
May 21
2025
|
Ronald V Da Vella |
BUY
Grant, award, or other acquisition
|
Direct |
4,995
+22.18%
|
-
|
|
May 21
2025
|
Suzanne M Decker |
BUY
Grant, award, or other acquisition
|
Direct |
4,995
+12.16%
|
-
|
|
Mar 10
2025
|
Sanjiv Kumar Razdan |
BUY
Grant, award, or other acquisition
|
Direct |
50,973
+36.41%
|
-
|
|
Mar 10
2025
|
Jake Singleton Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,936
+18.71%
|
-
|
|
Oct 14
2024
|
Sanjiv Kumar Razdan |
BUY
Grant, award, or other acquisition
|
Direct |
38,059
+50.0%
|
-
|
|
May 22
2024
|
Suzanne M Decker |
BUY
Grant, award, or other acquisition
|
Direct |
2,958
+8.69%
|
-
|
|
May 22
2024
|
Ronald V Da Vella |
BUY
Grant, award, or other acquisition
|
Direct |
2,958
+19.09%
|
-
|
Last 12 Months Summary
Buy / Acquisition
191K
Shares
From
11
Insiders
| Grant, award, or other acquisition | 117K shares |
|---|---|
| Open market or private purchase | 74.1K shares |
Sell / Disposition
0
Shares
From
0
Insiders